Record ID | marc_records_scriblio_net/part24.dat:70482604:1434 |
Source | Scriblio |
Download Link | /show-records/marc_records_scriblio_net/part24.dat:70482604:1434?format=raw |
LEADER: 01434cam 2200301 a 4500
001 94037226 //r952
003 DLC
005 19950829103710.2
008 941006s1995 dcuab b 101 0 eng c
010 $a 94037226 //r952
020 $a0841230730 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.T38$bT38 1994
060 10 $aQV 269 T235 1994
082 00 $a616.99/4061$220
110 2 $aAmerican Chemical Society.$bMeeting$n(207th :$d1994 :$cSan Diego, Calif.)
245 10 $aTaxane anticancer agents :$bbasic science and current status : developed from symposia sponsored by the Divisions of Chemical Health and Safety, Medicinal Chemistry, and Organic Chemistry at the 207th National Meeting of the American Chemical Society, San Diego, California, March 13-18, 1994 /$cGunda I. Georg, editor ... [et al.].
260 $aWashington, DC :$bThe Society,$c1995.
300 $axiii, 353 p. :$bill., map ;$c24 cm.
440 0 $aACS symposium series,$x0097-6156 ;$v583
504 $aIncludes bibliographical references and indexes.
650 0 $aPaclitaxel$xCongresses.
650 12 $aTaxol$xchemistry$xcongresses.
650 12 $aTaxol$xpharmacology$xcongresses.
700 1 $aGeorg, Gunda I.
710 2 $aAmerican Chemical Society.$bDivision of Chemical Health andSafety.
710 2 $aAmerican Chemical Society.$bDivision of Medicinal Chemistry.
710 2 $aAmerican Chemical Society.$bDivision of Organic Chemistry.